ArticleESHAP versus GEMOX in Management of Relapsed or Refractory Lymphoma: A Prospective Randomized Study
ArticleESHAP versus GEMOX in Management of Relapsed or Refractory Lymphoma: A Prospective Randomized Study
ArticleStudy of Outcome of Early Breast Cancer Patients Treated with Different Chemotherapy Protocols
ArticleStudy of Outcome of Early Breast Cancer Patients Treated with Different Chemotherapy Protocols
ArticleCOMPARATIVE STUDY BETWEEN PROADRENOMEDULLIN AND PROCALCITONIN, IN DIAGNOSING BACTERIAL INFECTIONS DURING FEBRILE NEUTROPENIA, IN ADULT ACUTE LEUKEMIC PATIENTS
ArticleCOMPARATIVE STUDY BETWEEN PROADRENOMEDULLIN AND PROCALCITONIN, IN DIAGNOSING BACTERIAL INFECTIONS DURING FEBRILE NEUTROPENIA, IN ADULT ACUTE LEUKEMIC PATIENTS
ArticleCOMPARISON BETWEEN CONCOMITANT CHEMO-RADIOTHERAPY WITH CISPLATIN VERSUS INDUCTION CHEMOTHERAPY FOLLOWED BY CONCOMITANT CHEMORADIOTHERAPY WITH CISPLATIN AND ETOPOSIDE REGIMEN IN C
ArticleCOMPARISON BETWEEN CONCOMITANT CHEMO-RADIOTHERAPY WITH CISPLATIN VERSUS INDUCTION CHEMOTHERAPY FOLLOWED BY CONCOMITANT CHEMORADIOTHERAPY WITH CISPLATIN AND ETOPOSIDE REGIMEN IN C
ArticleINTERLEUKIN 3 RECEPTOR (CD123) EXPRESSION IN ACUTE MYELOID LEUKAEMIA PATIENTS IN RELATION TO DISEASE CHARACTERISTICS AND TREATMENT OUTCOME
ArticleINTERLEUKIN 3 RECEPTOR (CD123) EXPRESSION IN ACUTE MYELOID LEUKAEMIA PATIENTS IN RELATION TO DISEASE CHARACTERISTICS AND TREATMENT OUTCOME
ArticleHyper-CVAD vs. BFM-Like Regimens in Adult Patients with Philadelphia-Negative Acute Lymphoblastic Leukemia: A Single-Center Experience
ArticleHyper-CVAD vs. BFM-Like Regimens in Adult Patients with Philadelphia-Negative Acute Lymphoblastic Leukemia: A Single-Center Experience
ArticleClinical Outcomes for Patients with Acute Myeloid Leukemia Harboring IDH1 Mutation After Intensive Chemotherapy
ArticleClinical Outcomes for Patients with Acute Myeloid Leukemia Harboring IDH1 Mutation After Intensive Chemotherapy
ArticleAn Innovative Epigenetic Merge in Treatment of AML Patients Correlates with Better "Molecular and Clinical” Outcomes
ArticleAn Innovative Epigenetic Merge in Treatment of AML Patients Correlates with Better "Molecular and Clinical” Outcomes
ArticleEVALUATION OF THE EFFICACY AND TOXICITY OF NEO-ADJUVANT SHORT COURSE RADIATION THERAPY CONCURRENTLY WITH CONTINUOUS INFUSION 5-FLUOROURACIL IN THE MANAGEMENT OF LOCALLY ADVANCED
ArticleEVALUATION OF THE EFFICACY AND TOXICITY OF NEO-ADJUVANT SHORT COURSE RADIATION THERAPY CONCURRENTLY WITH CONTINUOUS INFUSION 5-FLUOROURACIL IN THE MANAGEMENT OF LOCALLY ADVANCED